Viracta Therapeutics Inc (NASDAQ:VIRX)
| 3.97 Delayed Data As of Aug 08 |  +0.10 / +2.58%Today’s Change | 1.82 Today|||52-Week Range 11.57 | +8.77% Year-to-Date |
Latest VIRX News | Press Releases
No recent news for Viracta Therapeutics Inc.
Today’s Trading
| Previous close | 3.87 |
| Today’s open | 4.00 |
| Day’s range | 3.80 - 4.03 |
| Volume | 2,564 |
| Average volume (3 months) | 265,858 |
| Market cap | $151.5M |
Data as of 3:59pm ET, 08/08/2022
Growth & Valuation
| Earnings growth (last year) | +32.91% |
| Earnings growth (this year) | +66.28% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | 3.0 |
| Price/Sales | -- |
| Price/Book | 1.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SESNSesen Bio Inc | -0.00 | -0.16% |
| CTXRCitius Pharmaceutica... | +0.03 | +3.50% |
| PRTKParatek Pharmaceutic... | +0.14 | +5.36% |
| FSTXF-Star Therapeutics ... | +0.01 | +0.15% |
Data as of 3:59pm ET, 08/08/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$114.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cardiff, California |
Forecasts
